02087nas a2200229 4500000000100000008004100001260004600042653002400088653001600112100001100128700001000139700000900149700000900158700001100167700001100178245006200189856010700251300001000358490000600368520145800374022002501832 2020 d bOvid Technologies (Wolters Kluwer Health)10aInfectious Diseases10aDermatology1 aWang L1 aSun P1 aYu M1 aGu H1 aWang H1 aChen X00aEpidemiological Characteristics of Leprosy in China, 2018 uhttps://journals.lww.com/ijdv/Fulltext/2020/03000/Epidemiological_Characteristics_of_Leprosy_in.4.aspx a27-300 v33 a

Objective: 

To describe the epidemiological characteristics of leprosy in China in 2018 and provide the essential evidences for leprosy control.

Methods: 

We collected data of leprosy cases nationwide from Leprosy Management Information System in China (LEPMIS) except Hong Kong, Macao, and Taiwan. And then we performed a descriptive and comparative analysis.

Results: 

A total of 521 new leprosy cases were detected nationwide in 2018, with a case detection rate of 0.037/100,000. The proportion of children under 15 years of age, multi-bacillary (MB) cases, and cases with WHO grade 2 disability (G2D) were 1.3%, 89.4%, and 19.0%, respectively. There were 2,479 registered cases of leprosy in China by the end of 2018, accounting for a prevalence rate of 0.178/100,000, with 43 replase cases. Southwest China separately accounted for 312/521 (59.9%) newly detected cases and 1180/2479 (47.6%) registered cases of leprosy in China.

Conclusion: 

China is a low endemic country for leprosy and the detection rate was much lower than the global average. Southwest China is still the key regions for leprosy control, including Yunnan, Guizhou, and Sichuan. In addition, leprosy in low endemic provinces also needs to be focused.

 a2096-5540, 2641-8746